722444-62-4 Usage
Description
1-(5-aMino-1,3-dihydro-2H-isoindol-2-yl)-Ethanone, also known as 5-amino-1,3-dihydro-1-isoindol-2-yl-ethanone, is a chemical compound with the molecular formula C11H13NO2. It is an amino compound that features an isoindoline ring structure, making it a versatile building block in organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Research:
1-(5-aMino-1,3-dihydro-2H-isoindol-2-yl)-Ethanone is used as a building block for the synthesis of various functionalized compounds and bioactive molecules in the pharmaceutical industry. Its unique structural properties allow for the development of new therapeutic agents and pharmaceutical products.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(5-aMino-1,3-dihydro-2H-isoindol-2-yl)-Ethanone serves as an intermediate for the production of a wide range of compounds, including drugs, agrochemicals, and other fine chemicals. Its isoindoline ring structure contributes to the diversity and complexity of the synthesized products.
Used in Drug Development:
Due to its potential applications in the development of new therapeutic agents, 1-(5-aMino-1,3-dihydro-2H-isoindol-2-yl)-Ethanone is also utilized in the drug development industry. Its unique structural properties make it a valuable intermediate for creating innovative and effective pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 722444-62-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,2,4,4 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 722444-62:
(8*7)+(7*2)+(6*2)+(5*4)+(4*4)+(3*4)+(2*6)+(1*2)=144
144 % 10 = 4
So 722444-62-4 is a valid CAS Registry Number.
722444-62-4Relevant articles and documents
THIENODIAZEPINE DERIVATIVES AND APPLICATION THEREOF
-
Paragraph 0186; 0191-0192, (2020/08/09)
The present invention relates to a class of thienodiazepine derivatives and an application thereof in the preparation of a drug for the treatment of diseases associated with bromodomain and extra-terminal (BET) Bromodomain inhibitors. Specifically, the present invention relates to compounds represented by formulas (I) and (II), as well as pharmaceutically acceptable salts thereof.
